References
- Bachmann C, Bickel MH. (1985). History of drug metabolism: The first half of the 20th century. Drug Metab Rev 16:185–253
- Baumann MH, Solis E Jr, Watterson LR, et al. (2014). Baths salts, spice, and related designer drugs: The science behind the headlines. J Neurosci 34:15150–15158
- Brodie BB. (1967). Physicochemical and biochemical aspects of pharmacology. JAMA 202:600–609
- Caldwell J. (2006). Drug metabolism and pharmacogenetics: The British contribution to fields of international significance. Br J Pharmacol 147:S89–S99
- Caldwell J, Dring LG, Franklin RB, et al. (1977). Comparative metabolism of the amphetamine drugs of dependence in man and monkeys. J Med Primatol 6:367–375
- Channon HJ, Mills GT, Williams RT. (1944). The metabolism of 2:4:6-trinitrotoluene (alpha-T.N.T.). Biochem J 38:70–85
- Conti A, Bickel MH. (1977). History of drug metabolism: Discoveries of the major pathways in the 19th century. Drug Met Rev 6:1–50
- Dring LG, Franklin RB, Williams RT. (1975). The fate of amphetamine and norephedrine in the Tamarin monkey compared with man. West Afr J Pharmacol Drug Res 2:26–30
- Fabro S, Smith RL, Williams RT. (1965). Thalidomide as a possible biological acylating agent. Nature 208:1208–1209
- Fabro S, Smith RL, Williams RT. (1967). Toxicity and teratogenicity of optical isomers of thalidomide. Nature 215:296
- Gessner PK, Parke DV, Williams RT. (1961). Studies in detoxication. 86. The metabolism of 14C-labelled ethylene glycol. Biochem J 79:482–489
- Guengerich FP. (2008). Cytochrome p450 and chemical toxicology. Chem Res Toxicol 21:70–83
- Guengerich FP. (2015). Human cytochrome P450 enzymes. In: Oritz de Montellano PR, ed. Cytochrome P450 – Structure, metabolism and biochemistry. 4th edn. Heidelberg: Springer, 523–785
- Hodgman MJ, Garrard AR. (2012). A review of acetaminophen poisoning. Crit Care Clin 28:499–516
- Holmstedt B, Liljestrand G. (1963). Readings in pharmacology. London: Pergamon Press
- Jaffe M. (1874). Ueber das Verkalten des Nitrotoluols im thierischen organismus. Ber Dtsch Chem Ges 7:1673–1678
- Josephy PD, Guengerich FP, Miners JO. (2005). “Phase I and Phase II” drug metabolism: Terminology that we should phase out? Drug Metab Rev 37:575–580
- Kamil IA, Smith JN, Williams RT. (1953). Studies in detoxication. L. The isolation of methyl and ethyl glucuronides from the urine of rabbits receiving methanol and ethanol. Biochem J 54:390–392
- Kappas A, Alvares AP. (1975). How the liver metabolizes foreign substances. Sci Am 232:22–31
- Keller W. (1842). Ueber Verwanlung der Benzoesäure in Hippursäure. Ann Der Chem Pharm 43:108–111
- Liebreich O. (1869) Das Chloralhydrate ein neues hypnoticum und anaestheticum. Berlin: Otto Müller’s verlag
- Maurer HH. (2005). Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicology. Clin Biochem 38:310–318
- Meyer E, Van Bocxlaer JF, Lambert WE, et al. (1995). Determination of chloral hydrate and metabolites in a fatal intoxication. J Anal Toxicol 19:124–126
- Milne RW, Nation RL, Somogyi AA. (1996). The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine. Drug Metab Rev 28:345–472
- Mitchell SC, Waring RH. (1997). Drug metabolism at Birmingham, England: The Thorpe years, 1927-68. Xenobiotica 27:127–146
- Nebert DW, Wikvall K, Miller WL. (2013). Human cytochromes P450 in health and disease. Philos Trans R Soc Lond B Biol Sci 368:20120431
- Neuberger A, Smith RL. (1983a). Richard Tecwyn Williams: The man, his work, his impact. Drug Metab Rev 14:559–607
- Neuberger A, Smith RL. (1983b). Richard Tecwyn Williams: The man, his work, his impact. Biogr Mem Fellows R Soc 28:685–717
- Ortiz de Montellano PR. (2015). Cytochrome P450 – structure, mechanism and biochemistry. Heidelberg: Springer
- Parke DV. (1997). A history of drug metabolism in the United Kingdom. Drug Metab Rev 29:801–851
- Parke DV, Williams RT. (1969). Metabolism of toxic substances. Br Med Bull 25:256–262
- Pikuleva IA, Waterman MR. (2013). Cytochromes p450: Roles in diseases. J Biol Chem 288:17091–17098
- Pryde J, Williams RT. (1931). The pyranoid structure of glucuronic acid and of theophylline arabinoside. Nature 128:187
- Sever PS, Caldwell J, Dring LG, Williams RT. (1973). The metabolism of amphetamine in dependent subjects. Eur J Clin Pharmacol 6:177–180
- Siddik ZH, Barnes RD, Dring LG, et al. (1979). The fate of lysergic acid DI[14C]ethylamide ([14C]LSD) in the rat, guinea pig and rhesus monkey and of [14C]iso-LSD in rat. Biochem Pharmacol 28:3093–3101
- Smith RL, Williams RT. (1970) History of the discovery of the conjugation mechanisms. In: Fishman WH, ed. Metabolic conjugation and metabolic hydrolysis. New York: Academic Press, 1–19
- Stachulski AV, Lennard MS. (2000). Drug metabolism: The body’s defense against chemical attack. J Chem Ed 77:349–353
- Walsham NE, Sherwood RA. (2012). Ethyl glucuronide. Ann Clin Biochem 49:110–117
- Williams RT. (1932). Constitutional studies of biologically important carbohydrate derivatives: 1. The structure of theophylline arbinoside and 2. Glucuronic acid. PhD Thesis. UK: University of Wales
- Williams RT. (1947). Detoxication mechanisms. London: Chapman & Hall
- Williams RT. (1959). Detoxication mechanisms, 2nd edn. London: John Wiley & Sons
- Williams RT. (1963). Teratogenic effects of thalidomide and related substances. Lancet I: 723–724
- Williams RT. (1978). Species variations in the pathways of drug metabolism. Environ Health Perspect 22:133–138
- Williams RT, Parke DV. (1964). The metabolic fate of drugs. Ann Rev Pharmacol 4:85–114
- von Mering J, Musculus E. (1875). Ueber einen neuen Körper im Chloralharn. Ber Dtsch Chem Ges 8:662–666